Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment

NCT04933916 is registered in ClinicalTrials.gov with Embera NeuroTherapeutics, Inc. as lead sponsor.

NCT NCT04933916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04933916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Combination EMB-001 as a Potential Smoking Cessation Treatment
Lead sponsor
Embera NeuroTherapeutics, Inc.
Phase
Phase 1/2
Overall status
Terminated
Start date
June 10, 2021
Completion date
May 1, 2023
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

tobacco use disorder